- Final return
- −2.4%
- vs similar stocks
- −6.9 pp
Dates & source
- Fired
- Jul 9, 2026
- Exit date
- Oct 7, 2026
Buy Lab Coats & Lawmakers · ClinicalTrials.gov events
This looks for stocks that may rise. It flags a drug or biotech company when a clinical trial update lands and a U.S. House member also bought that same stock in the days just before. Pairing a trial event with a lawmaker's purchase is meant to be a double sign of confidence. Heads up: most of this came from a single recent year, so it may not repeat.
Newest idea 11 days ago
Updated Oct 17 · 1 feed behind: ClinicalTrials.gov events, 1 day · Every feed →
The planned holding period in these tests is 3 months (90 days), from opening to closing an idea.
At the next trading day’s close after the record posts — the first price anyone could have had.
The same hold for every idea — no stop, no target — so nothing flatters the numbers.
At the next available trading close on or after the end of the hold, whatever the price.
Every number on this page uses this sell rule — the other sell rules we tested are under “The full test results and the math” below.
Collecting forward evidence — past tests passed; new trades pending
Not passed yet — 3 of 16 checks:
Passed — the other 13: Current calculation · Public disclosure dates · Complete finished trades · Every trade compared · Every trade priced · Enough separate trading days · Positive edge after costs · Survives without the best year · Survives without the best three stocks · Survives higher costs · Rule frozen before the test · Rules tried alongside it counted · First new signals set aside.
Tested exit: 3-month hold. Historical results alone do not approve a rule for publication. New event tests include an estimated 0.20 percentage point round-trip trading cost, with a 0.50-point stress check.
New trades so far: 0 finished, across — separate days after the rule was frozen.
0 signals set aside across 0 disclosure days; 0 still need complete results. Missing results stay in the count.
Left: did worse · right: did better. Zero matches the comparison. pp = percentage points; the scale adjusts to include the result.
196 tries finished the 3-month test · 10 still open · 298 signals ever
Past results don't predict future ones.
Similar stocks means the index fund for each idea's sector — or the S&P 500 when we can't place its sector.
| How it did against similar stocks | 2.9 percentage points better than similar stocks — over 3 months |
|---|---|
| Range for the average (95%) | +0.6 pp to +5.3 pp vs similar stocks — the range the average probably falls in, not a best-to-worst case |
| Tested on enough tries? | 196 tries on 137 separate days ✓ enough |
| Works in different markets? | 61% from a single year ✓ spread across years |
| Spread across many stocks? | 24% from a single stock ✓ broad |
| Still works without its biggest winner? | +2.3 pp vs similar stocks without LLY ✓ holds up |
The 5 newest of 196 finished ideas: 1 of 5 beat similar stocks — one block each, newest first
did betterdid worseno comparison
LLY · Jul 9, 2026 · Return −2.4% · −6.9 pp vs similar stocks
pp = percentage points above or below the comparable stock return.
Week of Jul 13 · 2 ideas, weighted by signal strength, each sold 3 months after it fired — information to research, not an order to buy or sell.
Results under the 3-month hold · 10 still open · 196 finished · each idea's sell day is 3 months after it fired · an open idea shows its result so far.
| Stock | Fired | Status | Sell day | Result | vs similar stocks (pp) |
|---|---|---|---|---|---|
| LLY | Jul 9, 2026 | Finished | Oct 7, 2026 | −2.4% | −6.9 pp |
| JNJ | Jul 7, 2026 | Finished | Oct 5, 2026 | −5.1% | −7.3 pp |
| PFE | May 15, 2026 | Finished | Aug 13, 2026 | +7.5% | −9.1 pp |
| LLY | May 14, 2026 | Finished | Aug 12, 2026 | +21.2% | +5.8 pp |
| AMGN | Apr 23, 2026 | Finished | Jul 22, 2026 | +5.6% | −3.9 pp |
pp = percentage points: the return minus the comparable-stock return. A dash means the comparison is unavailable.
Showing 5 of 206 ideas
pp means percentage points: the difference between two returns. Actual returns are shown in %.
Held a year instead: +22.7% on average (141 tries).
Steadiness (Sharpe ratio) 0.88 — solid: how even the results were from one try to the next.
Every sell rule we tested, side by side, comes with membership.